PharmEnable, an innovative drug discovery firm, recently secured $7.5M in Pre-Series A financing, reflecting growing confidence in its proprietary AI-based …
Endogena Therapeutics, a biotech company that focuses on the first-in-class endogenous regenerative medicines, just announced treating the first patient with …
Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. …
Today, German artificial intelligence (AI) startup Vara published peer-reviewed research in Lancet Digital Health highlighting how a combination of AI …
A French-American healthcare unicorn Owkin, which applies artificial intelligence (AI) and federated learning frameworks to drug discovery, has just announced …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
